Literature DB >> 25294295

Evaluation of non-covalent interactions between serum albumin and green tea catechins by affinity capillary electrophoresis.

Angelo Zinellu1, Salvatore Sotgia2, Bastianina Scanu2, Elisabetta Pisanu2, Roberta Giordo2, Annalisa Cossu2, Anna Maria Posadino2, Ciriaco Carru2, Gianfranco Pintus3.   

Abstract

The natural antioxidant-associated biological responses appear contradictory since biologically active dosages registered in vitro experiments are considerably higher if compared to concentrations found in vivo. The recent research indicates that natural antioxidants, including the major catechins of green tea epicatechin (EC), epigallocatechin (EGC), epicatechingallate (ECG) and epigallocatechingallate (EGCG) form non-covalent complexes with albumin, a crucial aspect that may modulate their plasma concentration, tissue delivery and biological activity. Affinity capillary electrophoresis (ACE) was used to characterize the binding of the four catechins to human serum albumin (HSA) and bovine serum albumin (BSA) at near-physiological conditions: 10 mmol/L phosphate buffer, HEPES 50 mmol/L (pH 7.5), temperature 37°C. The studied flavonoids displayed affinities toward the albumin with binding constants in the range 10(3)-10(5)M(-1), with a greater affinity of catechins toward HSA than BSA (between 3 and 3.5 fold higher). We also confirmed that catechins having a galloyl moiety (ECG and EGCG) have a higher binding affinity toward albumin than the catechins lacking the galloyl moiety (EC and EGC), and that for both albumins the order of affinity is EC<EGC<ECG<EGCG. We believe that our work can provide useful information for better understanding the intercurrent relationships between cathechins bioavailability and their elicited biological effects.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affinity capillary electrophoresis; Albumin; Binding constant; Green tea, Catechins

Mesh:

Substances:

Year:  2014        PMID: 25294295     DOI: 10.1016/j.chroma.2014.09.053

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

Review 1.  [Advances in chromatography in the study of drug-plasma protein interactions].

Authors:  Yu Bai; Yufan Fan; Guangbo Ge; Fangjun Wang
Journal:  Se Pu       Date:  2021-10

2.  N- and S-homocysteinylation reduce the binding of human serum albumin to catechins.

Authors:  Angelo Zinellu; Salvatore Sotgia; Bastianina Scanu; Dionigia Arru; Annalisa Cossu; Anna Maria Posadino; Roberta Giordo; Arduino A Mangoni; Gianfranco Pintus; Ciriaco Carru
Journal:  Eur J Nutr       Date:  2015-12-10       Impact factor: 5.614

3.  FBS or BSA Inhibits EGCG Induced Cell Death through Covalent Binding and the Reduction of Intracellular ROS Production.

Authors:  Yin Zhang; Yu-Ying Xu; Wen-Jie Sun; Mo-Han Zhang; Yi-Fan Zheng; Han-Ming Shen; Jun Yang; Xin-Qiang Zhu
Journal:  Biomed Res Int       Date:  2016-10-18       Impact factor: 3.411

4.  Multi-site binding of epigallocatechin gallate to human serum albumin measured by NMR and isothermal titration calorimetry.

Authors:  Joshua D Eaton; Mike P Williamson
Journal:  Biosci Rep       Date:  2017-05-11       Impact factor: 3.840

5.  Human Serum Albumin Increases the Stability of Green Tea Catechins in Aqueous Physiological Conditions.

Authors:  Angelo Zinellu; Salvatore Sotgia; Bastianina Scanu; Mauro Forteschi; Roberta Giordo; Annalisa Cossu; Anna Maria Posadino; Ciriaco Carru; Gianfranco Pintus
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

Review 6.  Study on the interaction between active components from traditional Chinese medicine and plasma proteins.

Authors:  Qishu Jiao; Rufeng Wang; Yanyan Jiang; Bin Liu
Journal:  Chem Cent J       Date:  2018-05-04       Impact factor: 4.215

7.  Thermodynamic and computational analyses reveal the functional roles of the galloyl group of tea catechins in molecular recognition.

Authors:  Tomoya Takahashi; Satoru Nagatoishi; Daisuke Kuroda; Kouhei Tsumoto
Journal:  PLoS One       Date:  2018-10-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.